Gastrointestinal tract and the disorders of motility
Jamie is a 3-month-old female who presents with her mother for evaluation of “throwing up.” Mom reports that Jamie has been throwing up pretty much all the time since she was born. Jamie does not seem to be sick. In fact, she drinks her formula vigorously and often acts hungry. Jamie has normal soft-brown bowel movements every day and, overall, seems like a happy and contented baby. She smiles readily and does not cry often. Other than the fact that she often throws up after drinking a bottle, she seems to be a very healthy, happy infant. A more precise history suggests that Jamie does not exactly throw up—she does not heave or act unwell—but rather it just seems that almost every time she drinks a bottle she regurgitates a milky substance. Mom thought that she might be allergic to her formula and switched her to a hypoallergenic formula. It didn’t appear to help at all, and now Mom is very concerned.
Cases like these are not uncommon. The mother was concerned and thinking her daughter may have an allergy; she changed to a different formula. However, sometimes babies have immature GI tracts that can lead to physiology reflux as they adapt to normal life outside the uterus. Parents often do not consider this possibility, prompting them to change formulas rather than seeking medical care. As in the case study above, GI alterations can often be difficult to identify because many cause similar symptoms. This same issue also arises with adults—adults may present with symptoms that have various potential causes. When evaluating patients, it is important for the advanced practice nurse to know the types of questions he or she needs to ask to obtain the appropriate information for diagnosis. For this reason, you must have an understanding of common GI disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and gastritis.
To Prepare
· Review this week’s media presentation on the gastrointestinal system.
· Review Chapter 35 in the Huether and McCance text. Identify the normal pathophysiology of gastric acid stimulation and production.
· Review Chapter 37 in the Huether and McCance text. Consider the pathophysiology of gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and gastritis. Think about how these disorders are similar and different.
· Select a patient factor different from the one you selected in this week’s Discussion: ethnicity, or age. Consider how the factor you selected might impact the pathophysiology of GERD, PUD, and gastritis. Reflect on how you would diagnose and prescribe treatment of these disorders for a patient based on this factor.
To Complete
Write a 2- to 3-page paper that addresses the following:
- · Describe the normal pathophysiology of gastric acid stimulation and production. Explain the changes that occur to gastric acid stimulation and production with GERD, PUD, and gastritis disorders.
- · Explain how the factor you selected might impact the pathophysiology of GERD, PUD, and gastritis. Describe how you would diagnose and prescribe treatment of these disorders for a patient based on the factor you selected.
The Gastrointestinal Tract
Student’s Name
University
Course
Professor
Date
The Gastrointestinal Tract
Gastrointestinal Tract and the Disorders of Motility
“The gastrointestinal tract, or the digestive system as it’s commonly known, is more than just a tube that processes food – it’s a complex network of organs and tissues that plays a vital role in our overall health and well-being.” The gastrointestinal tract, also known as the digestive tract, is a long, muscular tube that runs from the mouth to the anus. It plays a crucial role in the digestion and absorption of food, as well as in eliminating waste from the body (Suen et al., 2019). The digestion process begins in the mouth, where enzymes in saliva begin to break down food into smaller particles. From there, the food travels down the esophagus and into the stomach, mixed with acid and enzymes to break it further down. The partially digested food then moves into the small intestine, where nutrients are absorbed into the bloodstream. The remaining waste products then pass into the large intestine, where water is reabsorbed and solid waste is eliminated through the rectum and anus. The gastrointestinal tract is a complex and highly coordinated system that ensures our bodies receive the necessary nutrients to function correctly.
The gastrointestinal tract, also known as the digestive system, is a complex network of organs responsible for processing food and extracting nutrients from it. The motility of the gastrointestinal tract refers to the coordinated movement of the muscles in the walls of the digestive organs, which propels food and waste products through the system (McQuilken, 2021). Motility disorders can affect any part of the digestive system and cause symptoms such as bloating, nausea, vomiting, constipation, or diarrhea. Some common motility disorders include irritable bowel syndrome, gastroparesis, esophageal motility disorders, and colonic inertia (Camilleri, 2018). Treatment for these disorders may involve medications, lifestyle modifications, or surgical interventions, depending on the severity of the condition. The essay will explore the normal pathophysiology of gastric acid stimulation and production and the changes that occur with these disorders. Additionally, a patient factor, such as age or ethnicity, will be selected to examine its impact on the pathophysiology of these disorders. The essay will conclude by discussing diagnostic and treatment approaches for these disorders based on age and ethnicity.
The Normal Pathophysiology of Gastric Acid Stimulation and Production
Gastric acid production and stimulation is a complex process that involves multiple cellular and chemical pathways. The stomach is lined with specialized cells called parietal cells responsible for gastric acid secretion (Baratta et al., 2019). Various factors, including the presence of food in the stomach, hormones, and neurotransmitters, tightly regulate the production and release of gastric acid. The process of gastric acid secretion begins with the activation of parietal cells by the hormone gastrin, which is released by specialized cells in the stomach called G cells in response to the presence of food. Gastrin stimulates the parietal cells to release hydrogen ions (H+) and chloride ions (Cl-) into the stomach lumen, which combine to form hydrochloric acid (HCl) (Wilson & Stevenson, 2019). Another critical factor in regulating gastric acid secretion is the vagus nerve, which stimulates parietal cells directly by releasing acetylcholine (Li et al., 2020). Histamine, produced by enterochromaffin-like cells in the stomach, also plays a crucial role in gastric acid production by stimulating parietal cells to release H+ ions. Various feedback mechanisms also regulate the release of gastric acid. When the pH of the stomach lumen becomes too acidic, the release of gastrin and histamine is inhibited, and the release of somatostatin is stimulated. Somatostatin inhibits the release of gastric acid by parietal cells, helping to maintain the pH of the stomach at an optimal level for digestion. Overall, the normal pathophysiology of gastric acid stimulation and production is a finely tuned process involving multiple factors and regulatory pathways to ensure optimal digestion and absorption of nutrients.
The Changes that Occur to Gastric Acid Stimulation and Production with GERD, PUD, and Gastritis Disorders
GERD, PUD, and gastritis are all gastrointestinal disorders that can lead to changes in the production and stimulation of gastric acid. In GERD, the lower esophageal sphincter (LES) that separates the esophagus from the stomach does not function properly, leading to the reflux of stomach contents into the esophagus (Fuchs et al., 2019). This can cause an increase in gastric acid production as a result of the stimulation of acid-secreting cells by refluxed stomach contents. PUD, on the other hand, is characterized by the formation of open sores or ulcers in the lining of the stomach or duodenum, which can be caused by an overgrowth of the bacteria Helicobacter pylori or the use of nonsteroidal anti-inflammatory drugs (NSAIDs) (Dawra et al., 2023). In PUD, gastric acid production is often increased due to the increased stimulation of acid-secreting cells by inflammatory mediators and the presence of H. pylori. Gastritis is an inflammation of the stomach lining and can be caused by various factors, including infection, autoimmune disorders, and certain medications (Herlihy & Feakins, 2022). In gastritis, gastric acid production may be decreased due to the damage or loss of acid-secreting cells in the stomach lining. These disorders can cause significant changes in the production and stimulation of gastric acid, leading to a range of symptoms and complications.
The Impact of Patient Factors such as Age and Ethnicity on the Pathophysiology of GERD, PUD, and Gastritis
The Impact of Age on the Pathophysiology of GERD, PUD, and Gastritis
Age significantly impacts the pathophysiology of GERD, PUD, and gastritis. GERD is more prevalent in older adults due to the aging-related weakening of the lower esophageal sphincter, which can lead to the backflow of stomach acid into the esophagus (Paz, 2019). In addition, older adults may have delayed gastric emptying, which can increase the risk of acid reflux. PUD is also more common in older adults, and the incidence increases with age (Espinosa et al., 2020). This is due to various factors, including the increased use of NSAIDs and aspirin in older adults and the decreased secretion of bicarbonate and mucus in the stomach lining. Furthermore, older adults are more likely to have chronic illnesses that can increase the risk of PUD, such as liver and kidney disease. Gastritis is also more prevalent in older adults, and chronic gastritis is associated with an increased risk of gastric cancer (Nishikawa et al., 2018). This is due to the aging-related changes in the gastric mucosa, including the reduction of mucous-secreting cells, the thinning of the mucosa, and the reduction of blood flow to the stomach lining. Overall, age-related changes in the digestive system can increase the risk of GERD, PUD, and gastritis, highlighting the importance of early diagnosis and treatment in older adults.
The Impact of Ethnicity on the Pathophysiology of GERD, PUD, and Gastritis
The impact of ethnicity on the pathophysiology of gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and gastritis is a complex and multifactorial issue involving genetic and environmental factors. Some studies have suggested that certain ethnic groups may be more susceptible to these gastrointestinal disorders than others (Loos & Van Dyke, 2020). For example, it has been shown that people of Asian descent are more likely to develop PUD and gastritis, while those of African descent may be more prone to GERD. One of the main factors contributing to these differences in susceptibility is thought to be genetics (Miller & Williams, 2021). Studies have identified genetic variations associated with an increased risk of developing GERD, PUD, and gastritis. For example, some studies have shown that people of Asian descent are more likely to have certain genetic variations that make them more susceptible to PUD and gastritis. Similarly, people of African descent are more likely to have genetic variations that increase their risk of developing GERD (Coleman et al., 2018). In addition to genetics, environmental factors also play a role in the pathophysiology of these gastrointestinal disorders. For example, dietary factors have been shown to contribute to developing GERD, PUD, and gastritis. People of Asian descent, for example, may be more likely to consume a diet high in salt and spicy foods, which can increase their risk of developing PUD and gastritis (Vahid & Davoodi, 2021). Similarly, people of African descent may be more likely to consume a diet high in fatty foods, which can contribute to developing GERD. The impact of ethnicity on the pathophysiology of GERD, PUD, and gastritis is a complex issue involving genetic and environmental factors. While certain ethnic groups may be more susceptible to these gastrointestinal disorders than others, it is essential to recognize that individual risk factors such as diet, lifestyle, and medical history also play a significant role in determining an individual’s risk of developing these conditions.
The Diagnosis of Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis Based on Age
The diagnosis of Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis can vary depending on the patient’s age. GERD is a condition where stomach acid flows back into the esophagus, causing discomfort and damage to the lining of the esophagus. PUD is a condition with a sore or ulcer in the stomach lining or small intestine. Gastritis is inflammation of the stomach lining. In younger patients, GERD is often diagnosed based on symptoms such as heartburn, regurgitation, and difficulty swallowing (Fass et al., 2021). These symptoms are often caused by lifestyle factors such as eating large meals, consuming spicy or acidic foods, or being overweight. The diagnosis may be confirmed by an upper endoscopy, which allows the doctor to visualize the esophagus and stomach and check for any damage. In older patients, PUD is more commonly diagnosed (Thiyagalingam et al., 2021). Symptoms of PUD can include abdominal pain, nausea, vomiting, and weight loss. Sometimes, PUD may be caused by an infection with the H. pylori. In older patients, PUD may be diagnosed using an upper endoscopy or a barium swallow test, which allows the doctor to visualize the ulcer or sore in the stomach or small intestine. Gastritis can affect patients of all ages, but it is more common in older adults (Conti et al., 2020). The diagnosis of gastritis may be based on symptoms such as abdominal pain, nausea, vomiting, and loss of appetite. An upper endoscopy may also be used to diagnose gastritis by visualizing stomach lining inflammation. In summary, the diagnosis of GERD, PUD, and gastritis can vary depending on the patient’s age. Younger patients may be diagnosed with GERD based on symptoms such as heartburn, while older patients may be diagnosed with PUD based on symptoms such as abdominal pain. Gastritis can affect patients of all ages, but it is more common in older adults and may be diagnosed based on symptoms such as abdominal pain and loss of appetite, as well as an upper endoscopy.
The Diagnosis of Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis Based on Ethnicity
The patient’s ethnicity can influence the diagnosis of gastrointestinal disorders such as Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis. For example, GERD is commonly diagnosed in individuals of Caucasian and Hispanic ethnicity (Lin et al., 2019). This may be due to differences in lifestyle factors, such as diet and obesity prevalence, linked to increased GERD incidence. In contrast, PUD is more prevalent in individuals of African and Asian descent (Walton et al., 2020). This may be due to genetic factors that influence the development of PUD, such as differences in the expression of genes involved in stomach acid regulation. Additionally, environmental factors such as infections with Helicobacter pylori, a bacteria known to cause PUD, may be more prevalent in these populations. Gastritis is a condition characterized by inflammation of the stomach lining, and its diagnosis can also be influenced by ethnicity (Chehade et al., 2018). For example, chronic atrophic gastritis is more commonly found in Asian populations and has been linked to dietary factors such as high intake of salt and nitrites in traditional Asian diets. In contrast, acute gastritis may be more commonly diagnosed in individuals of Hispanic and African descent, which may be due to differences in the prevalence of risk factors such as alcohol consumption. Overall, diagnosing gastrointestinal disorders such as GERD, PUD, and Gastritis should consider the patient’s ethnicity and potential differences in risk factors and genetic predisposition. This may help guide treatment decisions and improve outcomes for patients.
The Treatment of Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis Based on Age
Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis are common gastrointestinal disorders that affect people of all ages. The treatment of these conditions often varies depending on the patient’s age. Treatment for infants and children with GERD typically involves lifestyle modifications, such as smaller and more frequent feedings, thickening of formula or breast milk, and avoiding certain foods that can trigger reflux, such as spicy or acidic foods (Leung & Hon, 2019). In some cases, medication may also be prescribed to reduce acid production or improve the functioning of the lower esophageal sphincter. Treatment often focuses on lifestyle modifications in adolescents and young adults with GERD, but medication may be more commonly prescribed. Proton pump inhibitors (PPIs), which reduce acid production, are often the first-line treatment for GERD in this age group (Helgadottir, H., & Bjornsson, 2019). For adults with GERD, treatment may involve a combination of lifestyle modifications and medication. PPIs are often prescribed, but long-term use can have potential side effects. In some cases, surgical intervention may be necessary to alleviate symptoms. In children and adolescents with PUD, treatment often involves medication to reduce acid production and promote the healing of the ulcer. Surgery may sometimes be necessary (Sierra et al., 2018). Lifestyle modifications may also be recommended, such as avoiding certain foods that can exacerbate symptoms. In adults with PUD, treatment typically involves a combination of medication to reduce acid production and antibiotics to eradicate the bacteria responsible for the ulcer (if H. pylori cause it). Lifestyle modifications, such as quitting smoking and reducing alcohol consumption, may also be recommended. For individuals with gastritis, treatment often involves medication to reduce inflammation in the stomach lining (Johncilla et al., 2020). PPIs, H2 blockers, and antacids are commonly prescribed. Lifestyle modifications may also be recommended, such as avoiding spicy or acidic foods. GERD, PUD, and gastritis treatment vary depending on the patient’s age. While lifestyle modifications are often recommended for all age groups, medication and surgical intervention may be necessary in some cases, especially in adults. Working closely with a healthcare provider to develop an individualized treatment plan that considers the patient’s age, overall health, and specific symptoms is essential.
The Treatment of Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis Based on Ethnicity
The treatment of Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease (PUD), and Gastritis varies based on ethnicity, as specific populations are more predisposed to these conditions due to genetic factors, lifestyle, and dietary habits. In the case of GERD, individuals of Caucasian descent are more prone to this condition, and the treatment usually involves lifestyle modifications such as avoiding trigger foods, losing weight, and elevating the head of the bed (Landt et al., 2022). Medications such as proton pump inhibitors (PPIs) and H2 receptor blockers (H2 blockers) are also commonly prescribed to reduce acid production in the stomach and alleviate symptoms. On the other hand, Peptic Ulcer Disease (PUD) is more prevalent in African Americans, and treatment depends on the underlying cause (Malik et al., 2018). If a bacterial infection causes ulcers, antibiotics, PPIs, and H2 blockers may be prescribed to reduce acid production. Lifestyle modifications such as avoiding smoking, alcohol, and nonsteroidal anti-inflammatory drugs (NSAIDs) are also recommended. Gastritis, inflammation of the stomach lining, is more prevalent in Hispanics. The treatment for gastritis includes avoiding trigger foods, such as spicy and acidic foods, and reducing alcohol intake (Li et al., 2020). Medications such as antacids and PPIs may also be prescribed to reduce stomach acid and alleviate symptoms. In severe cases, hospitalization and intravenous medication may be required. GERD, PUD, and Gastritis treatment depends on the underlying cause and may vary based on ethnicity. Lifestyle modifications, medication, and dietary changes are all part of the treatment plan, and a healthcare professional should be consulted for personalized care.
Conclusion
In conclusion, the gastrointestinal tract is a complex system that plays a crucial role in the digestion and absorption of nutrients. Disorders of motility, such as gastroparesis and gastroesophageal reflux disease, can significantly impact the quality of life of affected individuals. Understanding the normal pathophysiology of gastric acid stimulation and production and the changes that occur with these disorders is critical to diagnosing and treating these conditions effectively. Furthermore, patient factors such as age and ethnicity can influence the pathophysiology of these disorders, which should be considered when choosing diagnostic and treatment approaches. Overall, with appropriate management, patients with gastrointestinal motility disorders can experience significant improvement in their symptoms and quality of life.
References
Baratta, V., Own, J., Di Renzo, C., Ollodart, J., Geibel, J. P., & Barahona, M. (2019). In Pursuit of the Parietal Cell–An Evolution of Scientific Methodology and Techniques. Frontiers in Physiology, 10, 1497. https://doi.org/10.3389/fphys.2019.01497
Camilleri, M. (2018). Cannabinoids and gastrointestinal motility: pharmacology, clinical effects, and potential therapeutics in humans. Neurogastroenterology & Motility, 30(9), e13370. https://doi.org/10.1111/nmo.13370
Chehade, M., Jones, S. M., Pesek, R. D., Burks, A. W., Vickery, B. P., Wood, R. A., … & Rothenberg, M. E. (2018). Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. The Journal of Allergy and Clinical Immunology: In Practice, 6(5), 1534-1544. https://doi.org/10.1016/j.jaip.2018.05.038
Coleman, H. G., Xie, S. H., & Lagergren, J. (2018). The epidemiology of esophageal adenocarcinoma. Gastroenterology, 154(2), 390-405. https://doi.org/10.1053/j.gastro.2017.07.046
Conti, L., Lenti, M. V., Di Sabatino, A., Miceli, E., Galli, G., Cazzato, M., … & Lahner, E. (2020). Seronegative autoimmune atrophic gastritis is more common in elderly patients. Digestive and Liver Disease, 52(11), 1310-1314. https://doi.org/10.1016/j.dld.2020.04.015
Dawra, S., Behl, P., Srivastava, S., Manrai, M., Chandra, A., Kumar, A., … & Tevatia, M. S. (2023). Non-neoplastic disorders in an aging gut: concise review. The Egyptian Journal of Internal Medicine, 35(1), 1-9.
Espinosa-Val, M. C., Martín-Martínez, A., Graupera, M., Arias, O., Elvira, A., Cabré, M., … & Ortega, O. (2020). Prevalence, risk factors, and complications of oropharyngeal dysphagia in older patients with dementia. Nutrients, 12(3), 863. https://doi.org/10.3390/nu12030863
Fass, R., Boeckxstaens, G. E., El-Serag, H., Rosen, R., Sifrim, D., & Vaezi, M. F. (2021). Gastro-oesophageal reflux disease. Nature reviews Disease primers, 7(1), 55.
Fuchs, K. H., Babic, B., & Fuchs, H. F. (2019). Esophageal sphincters in health and disease. In Shackelford’s Surgery of the Alimentary Tract, 2 Volume Set (pp. 2-10). Elsevier. https://doi.org/10.1016/B978-0-323-40232-3.00001-7
Helgadottir, H., & Bjornsson, E. S. (2019). Problems associated with deprescribing of proton pump inhibitors. International journal of molecular sciences, 20(21), 5469. https://doi.org/10.3390/ijms20215469
Herlihy, N., & Feakins, R. (2022). Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?. United European Gastroenterology Journal, 10(5), 451-464. https://doi.org/10.1002/ueg2.12242
Johncilla, M., Grover, S., Zhang, X., Jain, D., & Srivastava, A. (2020). Morphological spectrum of immune check‐point inhibitor therapy‐associated gastritis. Histopathology, 76(4), 531-539. https://doi.org/10.1111/his.14029
Landt, E. M., Çolak, Y., Nordestgaard, B. G., Lange, P., & Dahl, M. (2022). Risk and impact of chronic cough in obese individuals from the general population. Thorax, 77(3), 223-230. http://dx.doi.org/10.1136/thoraxjnl-2020-216351
Leung, A. K., & Hon, K. L. (2019). Gastroesophageal reflux in children: an updated review. Drugs in context, 8.
Li, X. J., You, X. Y., Wang, C. Y., Li, X. L., Sheng, Y. Y., Zhuang, P. W., & Zhang, Y. J. (2020). Bidirectional Brain‐gut‐microbiota Axis in increased intestinal permeability induced by central nervous system injury. CNS Neuroscience & Therapeutics, 26(8), 783-790. https://doi.org/10.1111/cns.13401
Li, Y., Su, Z., Li, P., Li, Y., Johnson, N., Zhang, Q., … & Ding, X. (2020). Association of symptoms with eating habits and food preferences in chronic gastritis patients: a cross-sectional study. Evidence-Based Complementary and Alternative Medicine, 2020. https://doi.org/10.1155/2020/5197201
Lin, E. C., Holub, J., Lieberman, D., & Hur, C. (2019). Low prevalence of suspected Barrett’s esophagus in patients with gastroesophageal reflux disease without alarm symptoms. Clinical Gastroenterology and Hepatology, 17(5), 857-863. https://doi.org/10.1016/j.cgh.2018.08.066
Loos, B. G., & Van Dyke, T. E. (2020). The role of inflammation and genetics in periodontal disease. Periodontology 2000, 83(1), 26-39. https://doi.org/10.1111/prd.12297
Malik, T. F., Gnanapandithan, K., & Singh, K. (2018). Peptic ulcer disease.
McQuilken, S. A. (2021). Gut motility and its control. Anaesthesia & Intensive Care Medicine, 22(5), 339-342. https://doi.org/10.1016/j.mpaic.2021.04.002
Miller, A. K., & Williams, S. M. (2021). Helicobacter pylori infection causes both protective and deleterious effects in human health and disease. Genes & Immunity, 22(4), 218-226.
Nishikawa, I., Kato, J., Terasoma, S., Matsutani, H., Tamaki, H., Tamaki, T., … & Ichinose, M. (2018). Nodular gastritis in association with gastric cancer development before and after Helicobacter pylori eradication. JGH Open, 2(3), 80-86. https://doi.org/10.1002/jgh3.12049
Paz, J. C. (2019). CHAPTER Gastrointestinal System. Acute Care Handbook for Physical Therapists E-Book, 4, 209.
Sierra, D., Wood, M., Kolli, S., & Felipez, L. M. (2018). Pediatric gastritis, gastropathy, and peptic ulcer disease. Pediatrics in review, 39(11), 542-549.
Suen, C. F. L. W., & De Cruz, P. (2019). The gastrointestinal tract: A brief introduction to healthy digestion. In Psychogastroenterology for Adults (pp. 3-17). Routledge.
Thiyagalingam, S., Kulinski, A. E., Thorsteinsdottir, B., Shindelar, K. L., & Takahashi, P. Y. (2021, February). Dysphagia in older adults. In Mayo Clinic Proceedings (Vol. 96, No. 2, pp. 488-497). Elsevier. https://doi.org/10.1016/j.mayocp.2020.08.001
Vahid, F., & Davoodi, S. H. (2021). Nutritional factors involved in the etiology of gastric cancer: a systematic review. Nutrition and cancer, 73(3), 376-390. https://doi.org/10.1080/01635581.2020.1756353
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., … & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Multiple Sclerosis Journal, 26(14), 1816-1821.
Wilson, R. L., & Stevenson, C. E. (2019). Anatomy and physiology of the stomach. In Shackelford’s Surgery of the Alimentary Tract, 2 Volume Set (pp. 634-646). Elsevier. https://doi.org/10.1016/B978-0-323-40232-3.00056-X
If you are having challenges with writing your nursing essay either because of lack of time or not knowing where to start, you can order your paper here